Ondek - Biologic Delivery Systems

Ondek Pty Ltd is an Australian biotechnology company developing a novel drug delivery platform, known as the Helicobacter pylori Platform Technology (HPPT).

The platform utilizes the unique characteristics of Helicobacter pylori bacterium to deliver a diverse range of therapeutics to the patient, including immune modulators, biopharmaceuticals or other drugs, and vaccines.

Ondek was founded by Professor Barry Marshall, a world authority and co-discoverer of the Helicobacter pylori organism and co-recipient of the 2005 Nobel Prize for Medicine and Physiology.